← Banco Bilbao Viscaya Argentaria SA ADR overview

Banco Bilbao Viscaya Argentaria SA ADR vs Agricultural Bank of China: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Banco Bilbao Viscaya Argentaria SA ADR (BBVA)

Q3 202617 Jun – 2 Aug 2026

▲3▼1

BBVA profit jumps, buyback launched; mortgage antitrust probe weighs

Strong H1 profit and €2bn buyback BBVA's first-half net profit rose 11.1% to €6.05bn, with Q2 profit up 11.4% and net interest income up 22.9%. It announced a €2bn share buyback, starting August 5. This directly boosts earnings and returns cash to shareholders, supporting the share price.
This is the core new financial result and capital return that drives the stock.
Shares surge on results BBVA shares jumped about 5% after the profit beat, helping lead a 2.6% rise in European bank stocks. The market reaction confirms investor confidence in the bank's performance and outlook.
It shows the immediate market impact of the earnings and buyback news.
Spanish antitrust probe into mortgage pricing Spain's competition authority opened proceedings against BBVA and five other banks over suspected anti-competitive conduct in mortgage pricing. The case could lead to fines or changes in how banks set rates, creating uncertainty and potential costs.
It is a new regulatory risk that could weigh on BBVA's price.
Capital relief from synthetic risk transfer BBVA was expected to close a synthetic risk transfer on AI infrastructure loans, reducing risk and freeing up capital for lending or returns. This helps the bank manage exposures and supports its capital position.
It shows a new capital management move that supports the bank's financial strength.

July 202617 Jun – 2 Aug 2026

▲3▼1

BBVA profit jumps, buyback launched; mortgage antitrust probe weighs

Strong H1 profit and €2bn buyback BBVA's first-half net profit rose 11.1% to €6.05bn, with Q2 profit up 11.4% and net interest income up 22.9%. It announced a €2bn share buyback, starting August 5. This directly boosts earnings and returns cash to shareholders, supporting the share price.
This is the core new financial result and capital return that drives the stock.
Shares surge on results BBVA shares jumped about 5% after the profit beat, helping lead a 2.6% rise in European bank stocks. The market reaction confirms investor confidence in the bank's performance and outlook.
It shows the immediate market impact of the earnings and buyback news.
Spanish antitrust probe into mortgage pricing Spain's competition authority opened proceedings against BBVA and five other banks over suspected anti-competitive conduct in mortgage pricing. The case could lead to fines or changes in how banks set rates, creating uncertainty and potential costs.
It is a new regulatory risk that could weigh on BBVA's price.
Capital relief from synthetic risk transfer BBVA was expected to close a synthetic risk transfer on AI infrastructure loans, reducing risk and freeing up capital for lending or returns. This helps the bank manage exposures and supports its capital position.
It shows a new capital management move that supports the bank's financial strength.

Latest17 Jun – 2 Aug 2026

▲3▼1

BBVA profit jumps, buyback launched; mortgage antitrust probe weighs

Strong H1 profit and €2bn buyback BBVA's first-half net profit rose 11.1% to €6.05bn, with Q2 profit up 11.4% and net interest income up 22.9%. It announced a €2bn share buyback, starting August 5. This directly boosts earnings and returns cash to shareholders, supporting the share price.
This is the core new financial result and capital return that drives the stock.
Shares surge on results BBVA shares jumped about 5% after the profit beat, helping lead a 2.6% rise in European bank stocks. The market reaction confirms investor confidence in the bank's performance and outlook.
It shows the immediate market impact of the earnings and buyback news.
Spanish antitrust probe into mortgage pricing Spain's competition authority opened proceedings against BBVA and five other banks over suspected anti-competitive conduct in mortgage pricing. The case could lead to fines or changes in how banks set rates, creating uncertainty and potential costs.
It is a new regulatory risk that could weigh on BBVA's price.
Capital relief from synthetic risk transfer BBVA was expected to close a synthetic risk transfer on AI infrastructure loans, reducing risk and freeing up capital for lending or returns. This helps the bank manage exposures and supports its capital position.
It shows a new capital management move that supports the bank's financial strength.

Agricultural Bank of China Ltd Class A (601288.CG)

Q3 202628 Aug – 8 Sep 2026

▲3

Beijing's 160bn yuan capital injection into ABC drives the period

H1 profit growth at a 2022 high Agricultural Bank of China reported 4.9% first-half net profit growth, its best since 2022, with bad loans stable. Falling deposit costs lifted margins even as new lending stayed weak. Solid earnings support the share price and the dividend investors rely on.
Earnings are the core driver of the bank's value and dividend appeal.
Property support lifts bank shares Beijing approved mortgage loans for completed housing projects and pushed local governments to boost home sales. Bank shares led the market higher, with Agricultural Bank up 1.91%. Better property demand means fewer bad loans and more mortgage lending for the bank.
Property is the biggest source of bank loan losses, so support directly lowers risk.
160bn yuan state capital injection Agricultural Bank will issue up to 160 billion yuan of new A-shares, with the Ministry of Finance subscribing 130 billion yuan and China Tobacco the rest. The cash goes straight into core capital, strengthening the balance sheet and its ability to lend and absorb losses.
This is the single largest new event of the period and directly boosts the bank's capital strength.
New shares dilute but strengthen The injection adds roughly 160 billion new shares, which spreads future profits over more shares and can cap near-term price gains. Analysts call it a planned policy move, not an emergency, and the extra capital supports lending through 2030. The benefit is long-term balance-sheet strength.
It is the honest counterweight: the same deal that strengthens capital also dilutes existing holders.

September 202628 Aug – 8 Sep 2026

▲3

Beijing's 160bn yuan capital injection into ABC drives the period

H1 profit growth at a 2022 high Agricultural Bank of China reported 4.9% first-half net profit growth, its best since 2022, with bad loans stable. Falling deposit costs lifted margins even as new lending stayed weak. Solid earnings support the share price and the dividend investors rely on.
Earnings are the core driver of the bank's value and dividend appeal.
Property support lifts bank shares Beijing approved mortgage loans for completed housing projects and pushed local governments to boost home sales. Bank shares led the market higher, with Agricultural Bank up 1.91%. Better property demand means fewer bad loans and more mortgage lending for the bank.
Property is the biggest source of bank loan losses, so support directly lowers risk.
160bn yuan state capital injection Agricultural Bank will issue up to 160 billion yuan of new A-shares, with the Ministry of Finance subscribing 130 billion yuan and China Tobacco the rest. The cash goes straight into core capital, strengthening the balance sheet and its ability to lend and absorb losses.
This is the single largest new event of the period and directly boosts the bank's capital strength.
New shares dilute but strengthen The injection adds roughly 160 billion new shares, which spreads future profits over more shares and can cap near-term price gains. Analysts call it a planned policy move, not an emergency, and the extra capital supports lending through 2030. The benefit is long-term balance-sheet strength.
It is the honest counterweight: the same deal that strengthens capital also dilutes existing holders.

Latest28 Aug – 8 Sep 2026

▲3

Beijing's 160bn yuan capital injection into ABC drives the period

H1 profit growth at a 2022 high Agricultural Bank of China reported 4.9% first-half net profit growth, its best since 2022, with bad loans stable. Falling deposit costs lifted margins even as new lending stayed weak. Solid earnings support the share price and the dividend investors rely on.
Earnings are the core driver of the bank's value and dividend appeal.
Property support lifts bank shares Beijing approved mortgage loans for completed housing projects and pushed local governments to boost home sales. Bank shares led the market higher, with Agricultural Bank up 1.91%. Better property demand means fewer bad loans and more mortgage lending for the bank.
Property is the biggest source of bank loan losses, so support directly lowers risk.
160bn yuan state capital injection Agricultural Bank will issue up to 160 billion yuan of new A-shares, with the Ministry of Finance subscribing 130 billion yuan and China Tobacco the rest. The cash goes straight into core capital, strengthening the balance sheet and its ability to lend and absorb losses.
This is the single largest new event of the period and directly boosts the bank's capital strength.
New shares dilute but strengthen The injection adds roughly 160 billion new shares, which spreads future profits over more shares and can cap near-term price gains. Analysts call it a planned policy move, not an emergency, and the extra capital supports lending through 2030. The benefit is long-term balance-sheet strength.
It is the honest counterweight: the same deal that strengthens capital also dilutes existing holders.